Equity Analysis

Company News

    Hikal Ltd
    Industry :  Pharmaceuticals - Indian - Bulk Drugs
    BSE Code
    ISIN Demat
    Book Value()
    524735
    INE475B01022
    97.5874153
    NSE Symbol
    P/E(TTM)
    Mar.Cap( Cr.)
    HIKAL
    63.59
    4735.98
    EPS(TTM)
    Face Value()
    Div & Yield %:
    6.04
    2
    0.31
     
Oil India Ltd - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Feb 14,2025
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 it is hereby informed that the Company will participate in Chasing the Growth an Investor Meet organised by Kotak Securities Limited in Mumbai on 20th February 2025. The Meeting is scheduled for Investor Group